$VYGR 3 SEC Filings

Filed On	Filing
18 May 2026	Form 3: Quinlan Amy, Principal Accounting Officer Holds 36,749 shares of Common Stock
08 Jan 2026	Form 3: Shiferman Gregory L., SVP and General Counsel No securities owned
09 Jul 2024	Form 3: Jorgensen Nathan D., Chief Financial Officer No securities owned
26 Mar 2024	Form 3: Ferguson Toby, Chief Medical Officer No securities owned
11 Jul 2023	Form 3: Fahey Sandell Jacquelyn, Chief Legal Officer No securities owned
11 May 2023	Form 3: Scangos George A, Director No securities owned
27 Feb 2023	Form 3: Onyia Jude, Director Holds 2,910 shares of Common Stock
04 Jan 2023	Form 3: Colon Grace, Director No securities owned
21 Sep 2022	Form 3: Carter Todd Alfred, Chief Scientific Officer Holds 36,194 shares of Common Stock
21 Sep 2022	Form 3: Pfreundschuh Peter P., Chief Financial Officer No securities owned
16 Aug 2022	Form 3: Mackey Catherine J, Director No securities owned
25 Apr 2022	Form 3: EcoR1 Capital, Llc, 10% owner Holds 4,276,507 shares of Common Stock
09 Feb 2022	Form 3: Swartz Robin, Chief Operating Officer Holds 58,000 shares of Common Stock
09 Feb 2022	Form 3: Sandrock Alfred, Director No securities owned
30 Nov 2021	Form 3: Burek Julie, Vice President, Finance Holds 33,022 shares of Common Stock
16 Sep 2020	Form 3: Vitale Nancy, Director No securities owned
22 May 2019	Form 3: Khwaja Omar, See Remarks No securities owned
03 Apr 2019	Form 3: Hesslein Robert W., Senior VP & General Counsel No securities owned
14 Mar 2019	Form 3: Neurocrine Biosciences Inc, 10% owner No securities owned
18 Jul 2018	Form 3: Turenne Andre, Director No securities owned

Comments